

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * regulation of protein activation cascade (GO:2000257) | 8.27847421 |
| 2 | complement activation, alternative pathway (GO:0006957) | 8.22203091 |
| 3 | * regulation of complement activation (GO:0030449) | 8.03057058 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 7.85143424 |
| 5 | regulation of fibrinolysis (GO:0051917) | 7.56440250 |
| 6 | protein carboxylation (GO:0018214) | 6.77454933 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.77454933 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.29255238 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 6.29255238 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.89410469 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 5.89410469 |
| 12 | blood coagulation, intrinsic pathway (GO:0007597) | 5.82128382 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.70431509 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 5.57426545 |
| 15 | exogenous drug catabolic process (GO:0042738) | 5.47504599 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 5.38628757 |
| 17 | negative regulation of sterol transport (GO:0032372) | 5.37023033 |
| 18 | negative regulation of cholesterol transport (GO:0032375) | 5.37023033 |
| 19 | fibrinolysis (GO:0042730) | 5.36586032 |
| 20 | * protein activation cascade (GO:0072376) | 5.29415456 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 5.29267602 |
| 22 | macromolecular complex remodeling (GO:0034367) | 5.29267602 |
| 23 | plasma lipoprotein particle remodeling (GO:0034369) | 5.29267602 |
| 24 | regulation of plasminogen activation (GO:0010755) | 5.28431931 |
| 25 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.26291728 |
| 26 | * regulation of apoptotic cell clearance (GO:2000425) | 5.24772297 |
| 27 | drug catabolic process (GO:0042737) | 5.23387867 |
| 28 | * complement activation, classical pathway (GO:0006958) | 5.22854679 |
| 29 | negative regulation of protein activation cascade (GO:2000258) | 5.21507401 |
| 30 | ethanol oxidation (GO:0006069) | 5.17620335 |
| 31 | omega-hydroxylase P450 pathway (GO:0097267) | 5.09252179 |
| 32 | cholesterol efflux (GO:0033344) | 5.08169270 |
| 33 | * complement activation (GO:0006956) | 4.97037030 |
| 34 | plasma lipoprotein particle assembly (GO:0034377) | 4.92106297 |
| 35 | high-density lipoprotein particle remodeling (GO:0034375) | 4.90362344 |
| 36 | glyoxylate metabolic process (GO:0046487) | 4.88749869 |
| 37 | intestinal cholesterol absorption (GO:0030299) | 4.85783465 |
| 38 | low-density lipoprotein particle remodeling (GO:0034374) | 4.81733832 |
| 39 | acute-phase response (GO:0006953) | 4.80645672 |
| 40 | * regulation of humoral immune response (GO:0002920) | 4.79259562 |
| 41 | phospholipid efflux (GO:0033700) | 4.78122970 |
| 42 | urea metabolic process (GO:0019627) | 4.72404836 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.62494947 |
| 44 | opsonization (GO:0008228) | 4.61223226 |
| 45 | plasma lipoprotein particle organization (GO:0071827) | 4.45905652 |
| 46 | protein-lipid complex assembly (GO:0065005) | 4.44648104 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.41530682 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.41530682 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 4.38528500 |
| 50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.37180481 |
| 51 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.37180481 |
| 52 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.28267806 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 4.27631438 |
| 54 | negative regulation of complement activation (GO:0045916) | 4.26964032 |
| 55 | ethanol metabolic process (GO:0006067) | 4.23411628 |
| 56 | protein-lipid complex subunit organization (GO:0071825) | 4.22819404 |
| 57 | urea cycle (GO:0000050) | 4.21529389 |
| 58 | aromatic amino acid family catabolic process (GO:0009074) | 4.19819142 |
| 59 | positive regulation of blood coagulation (GO:0030194) | 4.09723401 |
| 60 | positive regulation of hemostasis (GO:1900048) | 4.09723401 |
| 61 | cellular glucuronidation (GO:0052695) | 4.02810334 |
| 62 | negative regulation of coagulation (GO:0050819) | 4.02162504 |
| 63 | triglyceride homeostasis (GO:0070328) | 4.02089434 |
| 64 | acylglycerol homeostasis (GO:0055090) | 4.02089434 |
| 65 | glutamate metabolic process (GO:0006536) | 3.96423087 |
| 66 | negative regulation of wound healing (GO:0061045) | 3.93209527 |
| 67 | negative regulation of lipase activity (GO:0060192) | 3.88321565 |
| 68 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.85841582 |
| 69 | serine family amino acid catabolic process (GO:0009071) | 3.84645517 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 3.80115979 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 3.79288610 |
| 72 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.79229329 |
| 73 | cytolysis (GO:0019835) | 3.78448643 |
| 74 | bile acid metabolic process (GO:0008206) | 3.78257616 |
| 75 | uronic acid metabolic process (GO:0006063) | 3.76988340 |
| 76 | glucuronate metabolic process (GO:0019585) | 3.76988340 |
| 77 | bile acid biosynthetic process (GO:0006699) | 3.75527357 |
| 78 | positive regulation of coagulation (GO:0050820) | 3.75510895 |
| 79 | drug metabolic process (GO:0017144) | 3.75028370 |
| 80 | lipoprotein metabolic process (GO:0042157) | 3.62479815 |
| 81 | acute inflammatory response (GO:0002526) | 3.51649866 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 3.44068184 |
| 83 | response to mercury ion (GO:0046689) | 3.37175204 |
| 84 | negative regulation of humoral immune response (GO:0002921) | 3.35555755 |
| 85 | cholesterol transport (GO:0030301) | 3.34760708 |
| 86 | sterol transport (GO:0015918) | 3.34760708 |
| 87 | positive regulation of steroid metabolic process (GO:0045940) | 3.33968977 |
| 88 | regulation of cholesterol metabolic process (GO:0090181) | 3.33717881 |
| 89 | cholesterol homeostasis (GO:0042632) | 3.32456874 |
| 90 | tyrosine metabolic process (GO:0006570) | 3.32259444 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 3.31947092 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.29416009 |
| 93 | positive regulation of extracellular matrix organization (GO:1903055) | 3.28486257 |
| 94 | negative regulation of lipid transport (GO:0032369) | 3.27565579 |
| 95 | sterol homeostasis (GO:0055092) | 3.27240565 |
| 96 | * regulation of acute inflammatory response (GO:0002673) | 3.24404495 |
| 97 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.23715385 |
| 98 | proline metabolic process (GO:0006560) | 3.19582999 |
| 99 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.18379368 |
| 100 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.18379368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.29280672 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.70211302 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.80333938 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.74738953 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.34429879 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.24453566 |
| 7 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.17824178 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67590402 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.16499834 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.05253455 |
| 11 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.03353296 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.47952558 |
| 13 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.22961706 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18280608 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18172937 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.07202215 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.97249987 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83556233 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82446071 |
| 20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.80586044 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.67092931 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59604412 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56465490 |
| 24 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53510659 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42170928 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.40364167 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.40155014 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33628325 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31471854 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29785637 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23541966 |
| 32 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22828081 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22782437 |
| 34 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21436410 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20410497 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20325596 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16319945 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14927842 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12239335 |
| 40 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11036462 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10929463 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10284146 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06862163 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03378779 |
| 45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03016312 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02382677 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01353732 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00810471 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96834439 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96410933 |
| 51 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95663136 |
| 52 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95614483 |
| 53 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93248949 |
| 54 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90579039 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89735564 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88950285 |
| 57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88817210 |
| 58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88576914 |
| 59 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88556899 |
| 60 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88156174 |
| 61 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87456249 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86964575 |
| 63 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86163460 |
| 64 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85804055 |
| 65 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85357030 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85042407 |
| 67 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84493285 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83918467 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83586699 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81191791 |
| 71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81191791 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80228515 |
| 73 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76661225 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76651412 |
| 75 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.75899925 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75673963 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75393322 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75334831 |
| 79 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.75194814 |
| 80 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75188816 |
| 81 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.74937487 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 0.74876092 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74872098 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74580282 |
| 85 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.69784153 |
| 86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67957280 |
| 87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67490148 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67384987 |
| 89 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.66541061 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.66492947 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.66398269 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.63927603 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.61675934 |
| 94 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.61579226 |
| 95 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.59771934 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.59543671 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.58346657 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.57466074 |
| 99 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.56595722 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.56215399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.05322737 |
| 2 | MP0005360_urolithiasis | 5.92501760 |
| 3 | MP0005365_abnormal_bile_salt | 5.59128881 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.01759436 |
| 5 | MP0003195_calcinosis | 5.01074887 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.42243873 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.61420480 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.49106421 |
| 9 | MP0003252_abnormal_bile_duct | 3.32977735 |
| 10 | MP0009840_abnormal_foam_cell | 2.79474119 |
| 11 | MP0003868_abnormal_feces_composition | 2.76486604 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.73886837 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.41166448 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.36826669 |
| 15 | MP0005332_abnormal_amino_acid | 2.14800950 |
| 16 | MP0000609_abnormal_liver_physiology | 1.93834411 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 1.88916360 |
| 18 | MP0003122_maternal_imprinting | 1.81721990 |
| 19 | MP0005670_abnormal_white_adipose | 1.75663312 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.61114324 |
| 21 | MP0000566_synostosis | 1.59997669 |
| 22 | MP0003690_abnormal_glial_cell | 1.47823056 |
| 23 | MP0001915_intracranial_hemorrhage | 1.47276824 |
| 24 | MP0001661_extended_life_span | 1.45545605 |
| 25 | MP0000604_amyloidosis | 1.43878775 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.43254076 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.38822453 |
| 28 | MP0005451_abnormal_body_composition | 1.37454089 |
| 29 | MP0005408_hypopigmentation | 1.33808671 |
| 30 | MP0003879_abnormal_hair_cell | 1.21763887 |
| 31 | MP0002971_abnormal_brown_adipose | 1.20890809 |
| 32 | MP0002132_abnormal_respiratory_system | 1.19210545 |
| 33 | MP0005409_darkened_coat_color | 1.14012867 |
| 34 | MP0002089_abnormal_postnatal_growth/wei | 1.13529526 |
| 35 | MP0003329_amyloid_beta_deposits | 1.13059851 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.09851908 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.08567265 |
| 38 | MP0000598_abnormal_liver_morphology | 1.06317484 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.06160215 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.06116216 |
| 41 | MP0004272_abnormal_basement_membrane | 1.04138554 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.02930760 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.02553692 |
| 44 | MP0000639_abnormal_adrenal_gland | 1.00906500 |
| 45 | MP0001764_abnormal_homeostasis | 0.99358216 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.95761022 |
| 47 | MP0005023_abnormal_wound_healing | 0.95690425 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92350659 |
| 49 | MP0009697_abnormal_copulation | 0.90719458 |
| 50 | MP0008438_abnormal_cutaneous_collagen | 0.89005936 |
| 51 | MP0003011_delayed_dark_adaptation | 0.88496824 |
| 52 | MP0009642_abnormal_blood_homeostasis | 0.87458946 |
| 53 | MP0000920_abnormal_myelination | 0.86519489 |
| 54 | MP0000678_abnormal_parathyroid_gland | 0.83961704 |
| 55 | MP0003566_abnormal_cell_adhesion | 0.80862615 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 0.79044640 |
| 57 | MP0002249_abnormal_larynx_morphology | 0.78502817 |
| 58 | MP0002933_joint_inflammation | 0.76295226 |
| 59 | MP0003075_altered_response_to | 0.74193422 |
| 60 | MP0005164_abnormal_response_to | 0.72698529 |
| 61 | MP0002168_other_aberrant_phenotype | 0.72630227 |
| 62 | MP0000249_abnormal_blood_vessel | 0.71802871 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.71516973 |
| 64 | MP0005464_abnormal_platelet_physiology | 0.70630706 |
| 65 | MP0009115_abnormal_fat_cell | 0.68440700 |
| 66 | MP0009763_increased_sensitivity_to | 0.67040225 |
| 67 | MP0008469_abnormal_protein_level | 0.65801944 |
| 68 | MP0004883_abnormal_blood_vessel | 0.65452456 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.64950868 |
| 70 | MP0005257_abnormal_intraocular_pressure | 0.64836513 |
| 71 | MP0005448_abnormal_energy_balance | 0.64009760 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 0.63836102 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.63226771 |
| 74 | MP0003123_paternal_imprinting | 0.62959987 |
| 75 | MP0003632_abnormal_nervous_system | 0.62530946 |
| 76 | MP0001756_abnormal_urination | 0.60341207 |
| 77 | MP0002282_abnormal_trachea_morphology | 0.58300455 |
| 78 | MP0005334_abnormal_fat_pad | 0.56743401 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 0.55901901 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.55741051 |
| 81 | MP0005376_homeostasis/metabolism_phenot | 0.55273902 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.53907384 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.51370520 |
| 84 | MP0005395_other_phenotype | 0.50399017 |
| 85 | MP0003953_abnormal_hormone_level | 0.50263337 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.49029675 |
| 87 | MP0003633_abnormal_nervous_system | 0.48918584 |
| 88 | MP0005166_decreased_susceptibility_to | 0.47739056 |
| 89 | MP0005375_adipose_tissue_phenotype | 0.47335884 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.46838046 |
| 91 | MP0003878_abnormal_ear_physiology | 0.46838046 |
| 92 | MP0002896_abnormal_bone_mineralization | 0.46646304 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.46266508 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.44667278 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.44207516 |
| 96 | MP0003631_nervous_system_phenotype | 0.43667474 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.42642922 |
| 98 | MP0002970_abnormal_white_adipose | 0.42481951 |
| 99 | MP0005220_abnormal_exocrine_pancreas | 0.41855274 |
| 100 | MP0003950_abnormal_plasma_membrane | 0.41028725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Complement deficiency (HP:0004431) | 9.44468021 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.00008942 |
| 3 | * Abnormality of complement system (HP:0005339) | 7.49061733 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.08393151 |
| 5 | Joint hemorrhage (HP:0005261) | 6.69424197 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.54389722 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.25361711 |
| 8 | * Systemic lupus erythematosus (HP:0002725) | 5.66576632 |
| 9 | * Glomerulonephritis (HP:0000099) | 5.50147333 |
| 10 | Xanthomatosis (HP:0000991) | 5.32095457 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 5.24311740 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.89527101 |
| 13 | Spontaneous abortion (HP:0005268) | 4.52719320 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.18915091 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.13953389 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 4.05639059 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.98193497 |
| 18 | Hypercholesterolemia (HP:0003124) | 3.88644121 |
| 19 | Hemorrhage of the eye (HP:0011885) | 3.85146803 |
| 20 | * Nephritis (HP:0000123) | 3.74560734 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.44131895 |
| 22 | Menorrhagia (HP:0000132) | 3.34856391 |
| 23 | Mitral stenosis (HP:0001718) | 3.32271572 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.31242499 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.26230660 |
| 26 | Gingival bleeding (HP:0000225) | 3.24722973 |
| 27 | Fat malabsorption (HP:0002630) | 3.06976276 |
| 28 | Vascular calcification (HP:0004934) | 3.05779603 |
| 29 | Epidermoid cyst (HP:0200040) | 3.02625268 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.80422385 |
| 31 | Cardiovascular calcification (HP:0011915) | 2.73945436 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.64760132 |
| 33 | Myocardial infarction (HP:0001658) | 2.63488638 |
| 34 | Hepatocellular carcinoma (HP:0001402) | 2.47822869 |
| 35 | Rickets (HP:0002748) | 2.46980070 |
| 36 | Skin nodule (HP:0200036) | 2.37886103 |
| 37 | * Thrombophlebitis (HP:0004418) | 2.26084636 |
| 38 | Acanthocytosis (HP:0001927) | 2.21962605 |
| 39 | Abnormality of carpal bone ossification (HP:0006257) | 2.18627211 |
| 40 | * Purpura (HP:0000979) | 2.16815374 |
| 41 | Osteomalacia (HP:0002749) | 2.15048336 |
| 42 | Facial shape deformation (HP:0011334) | 2.11310064 |
| 43 | Potter facies (HP:0002009) | 2.11310064 |
| 44 | Amyloidosis (HP:0011034) | 2.07633424 |
| 45 | Hyperammonemia (HP:0001987) | 2.06983249 |
| 46 | Hypophosphatemic rickets (HP:0004912) | 2.06210037 |
| 47 | Abnormal tarsal ossification (HP:0008369) | 2.01788179 |
| 48 | Steatorrhea (HP:0002570) | 2.00414685 |
| 49 | Deep venous thrombosis (HP:0002625) | 10.3230278 |
| 50 | Hydroxyprolinuria (HP:0003080) | 1.99429380 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 1.99429380 |
| 52 | Arthropathy (HP:0003040) | 1.98562874 |
| 53 | Protrusio acetabuli (HP:0003179) | 1.97453204 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.97058199 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 1.97058199 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 1.96096137 |
| 57 | Hyperglycinemia (HP:0002154) | 1.90475583 |
| 58 | Delayed CNS myelination (HP:0002188) | 1.89184838 |
| 59 | Abnormal delivery (HP:0001787) | 1.88898012 |
| 60 | Abnormality of the Achilles tendon (HP:0005109) | 1.88211536 |
| 61 | Flat acetabular roof (HP:0003180) | 1.86497774 |
| 62 | Joint swelling (HP:0001386) | 1.86096425 |
| 63 | Epistaxis (HP:0000421) | 1.83928947 |
| 64 | Hyperglycinuria (HP:0003108) | 1.83381459 |
| 65 | Bifid scrotum (HP:0000048) | 1.81965807 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 1.81165323 |
| 67 | Esophageal varix (HP:0002040) | 1.73926595 |
| 68 | Small epiphyses (HP:0010585) | 1.73872716 |
| 69 | Enlarged kidneys (HP:0000105) | 1.72600892 |
| 70 | Abnormal ossification of hand bones (HP:0005921) | 1.69943176 |
| 71 | Poikilocytosis (HP:0004447) | 1.69334508 |
| 72 | Generalized aminoaciduria (HP:0002909) | 1.68294252 |
| 73 | Abnormal hand bone ossification (HP:0010660) | 1.66985496 |
| 74 | Asymmetry of the thorax (HP:0001555) | 1.66212878 |
| 75 | Gout (HP:0001997) | 1.65811726 |
| 76 | Peritonitis (HP:0002586) | 1.64531425 |
| 77 | * Pulmonary embolism (HP:0002204) | 1.61676865 |
| 78 | Neurofibrillary tangles (HP:0002185) | 1.59516501 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.59096291 |
| 80 | Mucopolysacchariduria (HP:0008155) | 1.59096291 |
| 81 | Alacrima (HP:0000522) | 1.58205904 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 1.56632334 |
| 83 | Cholecystitis (HP:0001082) | 1.56632334 |
| 84 | Cerebral aneurysm (HP:0004944) | 1.55732743 |
| 85 | Increased serum ferritin (HP:0003281) | 1.54604505 |
| 86 | Widely patent fontanelles and sutures (HP:0004492) | 1.54553091 |
| 87 | Hyperbilirubinemia (HP:0002904) | 1.53812509 |
| 88 | Bronchomalacia (HP:0002780) | 1.51332541 |
| 89 | Hypertriglyceridemia (HP:0002155) | 1.50645713 |
| 90 | Back pain (HP:0003418) | 1.49818171 |
| 91 | Elevated alkaline phosphatase (HP:0003155) | 1.48902240 |
| 92 | Pigmentary retinal degeneration (HP:0001146) | 1.48474243 |
| 93 | Increased serum pyruvate (HP:0003542) | 1.47254772 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 1.46368981 |
| 95 | Hypophosphatemia (HP:0002148) | 1.45513648 |
| 96 | Abnormality of purine metabolism (HP:0004352) | 1.42851035 |
| 97 | Neonatal onset (HP:0003623) | 1.42600066 |
| 98 | Hypoglycemic coma (HP:0001325) | 1.41774913 |
| 99 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.41662677 |
| 100 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.41407908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 5.98017356 |
| 2 | ERN1 | 4.03009583 |
| 3 | RIPK1 | 3.63137613 |
| 4 | FGFR3 | 3.63133864 |
| 5 | TRIB3 | 3.28315619 |
| 6 | ICK | 3.09565163 |
| 7 | SIK1 | 2.91235932 |
| 8 | PDGFRA | 2.34455113 |
| 9 | EPHA3 | 2.03898266 |
| 10 | AKT3 | 1.98798284 |
| 11 | WNK4 | 1.83004233 |
| 12 | CDK12 | 1.81153366 |
| 13 | MST1R | 1.76556486 |
| 14 | PIK3CA | 1.74604827 |
| 15 | PKN2 | 1.64301009 |
| 16 | DDR2 | 1.61852306 |
| 17 | TYRO3 | 1.61203407 |
| 18 | FGFR2 | 1.56279209 |
| 19 | RET | 1.51341406 |
| 20 | PRKAA2 | 1.50704447 |
| 21 | NTRK3 | 1.44885700 |
| 22 | EPHB1 | 1.33874681 |
| 23 | TYK2 | 1.30982821 |
| 24 | PDPK1 | 1.28987451 |
| 25 | TGFBR2 | 1.25313724 |
| 26 | EEF2K | 1.24394014 |
| 27 | ERBB2 | 1.23077800 |
| 28 | MET | 1.20013873 |
| 29 | JAK1 | 1.14944887 |
| 30 | EPHA2 | 1.13685841 |
| 31 | MAP3K2 | 1.10628777 |
| 32 | MAPK11 | 1.07914703 |
| 33 | FGFR1 | 1.07867493 |
| 34 | MAP3K3 | 1.05161186 |
| 35 | SGK494 | 1.04782848 |
| 36 | SGK223 | 1.04782848 |
| 37 | DYRK1B | 1.00924327 |
| 38 | CDC42BPA | 0.97795343 |
| 39 | WNK1 | 0.96622434 |
| 40 | FER | 0.95848726 |
| 41 | PDK1 | 0.86979694 |
| 42 | MTOR | 0.86966735 |
| 43 | LATS1 | 0.86503656 |
| 44 | MAP3K7 | 0.86434517 |
| 45 | NTRK1 | 0.86340762 |
| 46 | SGK3 | 0.84290934 |
| 47 | NEK9 | 0.81600329 |
| 48 | NLK | 0.81256642 |
| 49 | MAP3K6 | 0.80679732 |
| 50 | MAP3K1 | 0.80522838 |
| 51 | SMG1 | 0.80432057 |
| 52 | PDGFRB | 0.80343893 |
| 53 | MARK2 | 0.79786919 |
| 54 | PRKACG | 0.78957593 |
| 55 | PTK6 | 0.76556575 |
| 56 | LATS2 | 0.76494011 |
| 57 | MAPKAPK3 | 0.74462537 |
| 58 | SGK2 | 0.73695676 |
| 59 | PRKAA1 | 0.70828776 |
| 60 | PTK2 | 0.69956870 |
| 61 | SGK1 | 0.69347995 |
| 62 | SIK2 | 0.62011956 |
| 63 | LMTK2 | 0.59463092 |
| 64 | MAP2K6 | 0.57440627 |
| 65 | PRPF4B | 0.56065909 |
| 66 | IGF1R | 0.54950675 |
| 67 | EPHA4 | 0.53132494 |
| 68 | CSF1R | 0.52577842 |
| 69 | JAK2 | 0.52232145 |
| 70 | STK38 | 0.51876930 |
| 71 | NEK6 | 0.50533399 |
| 72 | KSR2 | 0.49868868 |
| 73 | ZAP70 | 0.49476827 |
| 74 | SRC | 0.47689805 |
| 75 | IRAK3 | 0.47569037 |
| 76 | CAMK1D | 0.47207275 |
| 77 | PRKCZ | 0.46501542 |
| 78 | MAPK12 | 0.42605783 |
| 79 | RPS6KB1 | 0.42040185 |
| 80 | MAPK3 | 0.41914129 |
| 81 | NTRK2 | 0.41156959 |
| 82 | GSK3A | 0.40979871 |
| 83 | MAPK15 | 0.37366679 |
| 84 | RPS6KA3 | 0.35346993 |
| 85 | CDK6 | 0.34679974 |
| 86 | CSNK1E | 0.34181953 |
| 87 | PRKG1 | 0.34027500 |
| 88 | MELK | 0.33073169 |
| 89 | MAPK10 | 0.32703783 |
| 90 | HIPK2 | 0.32033418 |
| 91 | PRKD1 | 0.31923841 |
| 92 | MAP2K4 | 0.31827264 |
| 93 | CAMK4 | 0.30957193 |
| 94 | CDK7 | 0.29116038 |
| 95 | FGR | 0.28458166 |
| 96 | MAPK1 | 0.28180255 |
| 97 | TBK1 | 0.27360808 |
| 98 | MYLK | 0.27220748 |
| 99 | MAP3K5 | 0.27047937 |
| 100 | MAPK4 | 0.24217902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 5.16313988 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.08259783 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.07407335 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.93409209 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.81145205 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.78687502 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.70118365 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69686944 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.51975861 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51065371 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.39670665 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39625100 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36136373 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.25144269 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.23985053 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.23598421 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.22929384 |
| 18 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00189026 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.95267983 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.94506862 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92381193 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73662528 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73339371 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.68002157 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.61384117 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58801282 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57614618 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54965009 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54153140 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53517449 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51990297 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48400053 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47878871 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23244281 |
| 35 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.21791097 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.19402313 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18736022 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15752654 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15611024 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.09424101 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07695680 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.07360644 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01906450 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90556935 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88952224 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83438844 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81607708 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80246305 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78660524 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78403559 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77616671 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76688216 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76043522 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75836891 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74753959 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69143255 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65190201 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61192691 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.61173514 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60650996 |
| 61 | * Pertussis_Homo sapiens_hsa05133 | 0.60421408 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56303496 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53467952 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.51602536 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50452960 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45863887 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41349922 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40938291 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40107718 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33063658 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31420914 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27613447 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27010004 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.26070668 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25951409 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23084436 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.21321307 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.19816732 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.17838584 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13440405 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12958121 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12756019 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12549782 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10549738 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10022597 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08181091 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.06877235 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.06037743 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.04355056 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.02085124 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.01210026 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.01051834 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | -0.0770764 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0767605 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0759707 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0658845 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0647401 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0519305 |
| 99 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0189249 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0052866 |

